• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 住院后 3 个月和 12 个月的 CT 异常与疾病严重程度的关系:一项前瞻性队列研究。

CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study.

机构信息

Department of Radiology and Nuclear Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

PLoS One. 2024 May 6;19(5):e0302896. doi: 10.1371/journal.pone.0302896. eCollection 2024.

DOI:10.1371/journal.pone.0302896
PMID:38709747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11073708/
Abstract

OBJECTIVES

To investigate changes in chest CT between 3 and 12 months and associations with disease severity in patients hospitalized for COVID-19 during the first wave in 2020.

MATERIALS AND METHODS

Longitudinal cohort study of patients hospitalized for COVID-19 in 2020. Chest CT was performed 3 and 12 months after admission. CT images were evaluated using a CT severity score (CSS) (0-12 scale) and recoded to an abbreviated version (0-3 scale). We analyzed determinants of the abbreviated CSS with multivariable mixed effects ordinal regression.

RESULTS

242 patients completed CT at 3 months, and 124 (mean age 62.3±13.3, 78 men) also at 12 months. Between 3 and 12 months (n = 124) CSS (0-12 scale) for ground-glass opacities (GGO) decreased from median 3 (25th-75th percentile: 0-12) at 3 months to 0.5 (0-12) at 12 months (p<0.001), but increased for parenchymal bands (p<0.001). In multivariable analysis of GGO, the odds ratio for more severe abbreviated CSS (0-3 scale) at 12 months was 0.11 (95%CI 0.11 0.05 to 0.21, p<0.001) compared to 3 months, for WHO severity category 5-7 (high-flow oxygen/non-invasive ventilation/ventilator) versus 3 (non-oxygen use) 37.16 (1.18 to 43.47, p = 0.032), and for age ≥60 compared to <60 years 4.8 (1.33 to 17.6, p = 0.016). Mosaicism was reduced at 12 compared to 3 months, OR 0.33 (95%CI 0.16 to 0.66, p = 0.002).

CONCLUSIONS

GGO and mosaicism decreased, while parenchymal bands increased from 3 to 12 months. Persistent GGO were associated with initial COVID-19 severity and age ≥60 years.

摘要

目的

研究 2020 年 COVID-19 第一波期间住院患者在 3 至 12 个月期间的胸部 CT 变化,并探讨其与疾病严重程度的关系。

材料和方法

对 2020 年 COVID-19 住院患者进行纵向队列研究。入院后 3 个月和 12 个月进行胸部 CT 检查。使用 CT 严重程度评分(CSS)(0-12 分)评估 CT 图像,并将其重新编码为缩写版本(0-3 分)。我们使用多变量混合效应有序回归分析缩写 CSS 的决定因素。

结果

242 例患者在 3 个月时完成 CT 检查,124 例(平均年龄 62.3±13.3,78 例男性)在 12 个月时也完成 CT 检查。在 3 至 12 个月(n=124)期间,磨玻璃影(GGO)的 CSS(0-12 分)中位数从 3 个月时的 3(25 至 75 分位:0-12)降至 12 个月时的 0.5(0-12)(p<0.001),但实质带的 CSS 增加(p<0.001)。多变量分析 GGO 时,与 3 个月相比,12 个月时更严重的缩写 CSS(0-3 分)的比值比为 0.11(95%CI 0.11 0.05 至 0.21,p<0.001),与 WHO 严重程度类别 5-7(高流量氧/无创通气/呼吸机)与 3(非吸氧)相比,37.16(1.18 至 43.47,p=0.032),与年龄≥60 岁相比,年龄<60 岁的比值为 4.8(1.33 至 17.6,p=0.016)。与 3 个月相比,12 个月时镶嵌征减少,OR 0.33(95%CI 0.16 至 0.66,p=0.002)。

结论

从 3 个月到 12 个月,GGO 和镶嵌征减少,而实质带增加。持续的 GGO 与初始 COVID-19 严重程度和年龄≥60 岁有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/11a79a41175a/pone.0302896.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/056638b4bf84/pone.0302896.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/f250cdfdfe86/pone.0302896.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/fd6d01a0f6aa/pone.0302896.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/864e6b128e54/pone.0302896.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/11a79a41175a/pone.0302896.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/056638b4bf84/pone.0302896.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/f250cdfdfe86/pone.0302896.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/fd6d01a0f6aa/pone.0302896.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/864e6b128e54/pone.0302896.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ad3/11073708/11a79a41175a/pone.0302896.g005.jpg

相似文献

1
CT abnormalities 3 and 12 months after hospitalization for COVID-19 and association with disease severity: A prospective cohort study.COVID-19 住院后 3 个月和 12 个月的 CT 异常与疾病严重程度的关系:一项前瞻性队列研究。
PLoS One. 2024 May 6;19(5):e0302896. doi: 10.1371/journal.pone.0302896. eCollection 2024.
2
Chest CT Findings at Six Months Following COVID-19 ARDS - Correlation With the mMRC Dyspnea Scale and Pulmonary Function Tests.COVID-19 后 ARDS 患者 6 个月时的胸部 CT 表现与 mMRC 呼吸困难量表和肺功能测试的相关性。
Br J Biomed Sci. 2024 Jul 10;81:12871. doi: 10.3389/bjbs.2024.12871. eCollection 2024.
3
Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.对 COVID-19 患者基线胸部 CT 上的临床和实验室数据、放射学结构化报告结果以及肺部受累的定量评估,以预测其预后。
Radiol Med. 2021 Jan;126(1):29-39. doi: 10.1007/s11547-020-01293-w. Epub 2020 Oct 12.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].新型冠状病毒肺炎患者胸部CT评分的时空分布及预测价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):230-236. doi: 10.3760/cma.j.cn112147-20200522-00626.
6
Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia.重症 COVID-19 肺炎患者 6 个月随访的胸部 CT 结果。
Radiology. 2021 Apr;299(1):E177-E186. doi: 10.1148/radiol.2021203153. Epub 2021 Jan 26.
7
Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.COVID-19 住院 3 个月后的呼吸困难、肺功能和 CT 表现。
Eur Respir J. 2021 Apr 29;57(4). doi: 10.1183/13993003.03448-2020. Print 2021 Apr.
8
Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19).多中心研究:住院的新型冠状病毒肺炎(COVID-19)患者 CT 视觉严重程度评分的时间变化及其预后价值。
AJR Am J Roentgenol. 2021 Jul;217(1):83-92. doi: 10.2214/AJR.20.24044. Epub 2020 Sep 9.
9
Correlation between ground-glass opacity on pulmonary CT and the levels of inflammatory cytokines in patients with moderate-to-severe COVID-19 pneumonia.肺 CT 磨玻璃密度与中重度 COVID-19 肺炎患者炎症细胞因子水平的相关性。
Int J Med Sci. 2021 Apr 16;18(11):2394-2400. doi: 10.7150/ijms.56683. eCollection 2021.
10
Association of chest computed tomography severity score at ICU admission and respiratory outcomes in critically ill COVID-19 patients.入住 ICU 时的胸部 CT 严重程度评分与危重症 COVID-19 患者的呼吸结局的相关性。
PLoS One. 2024 May 2;19(5):e0299390. doi: 10.1371/journal.pone.0299390. eCollection 2024.

本文引用的文献

1
Radiological pulmonary sequelae after COVID-19 and correlation with clinical and functional pulmonary evaluation: results of a prospective cohort.COVID-19 后的放射学肺部后遗症与临床和功能肺部评估的相关性:一项前瞻性队列研究的结果。
Eur Radiol. 2024 Feb;34(2):1037-1052. doi: 10.1007/s00330-023-10044-0. Epub 2023 Aug 12.
2
Chest CT Findings 1 Year after COVID-19: Another Piece of the Post-Pandemic Puzzle.新冠病毒感染后1年的胸部CT表现:大流行后谜题的又一片拼图。
Radiology. 2023 Jul;308(1):e231502. doi: 10.1148/radiol.231502.
3
Chest CT Lung Abnormalities 1 Year after COVID-19: A Systematic Review and Meta-Analysis.
COVID-19 后 1 年的胸部 CT 肺部异常:系统评价和荟萃分析。
Radiology. 2023 Jul;308(1):e230535. doi: 10.1148/radiol.230535.
4
A prospective study of pulmonary outcomes and chest computed tomography in the first year after COVID-19.一项关于COVID-19后第一年肺部结局和胸部计算机断层扫描的前瞻性研究。
ERJ Open Res. 2023 Mar 13;9(2). doi: 10.1183/23120541.00575-2022. eCollection 2023 Mar.
5
Clinical and radiological outcomes of longCOVID: Is the post-COVID fibrosis common?长新冠的临床和影像学结果:新冠后纤维化是否常见?
Tuberk Toraks. 2023 Mar;71(1):48-57. doi: 10.5578/tt.20239907.
6
Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.COVID-19 康复后 6-12 个月的肺功能和胸部计算机断层扫描异常:系统评价和荟萃分析。
Respir Res. 2022 Sep 6;23(1):233. doi: 10.1186/s12931-022-02163-x.
7
Long-term Lung Abnormalities Associated with COVID-19 Pneumonia.与 COVID-19 肺炎相关的长期肺部异常。
Radiology. 2023 Feb;306(2):e221806. doi: 10.1148/radiol.221806. Epub 2022 Aug 30.
8
Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.与德尔塔变异株感染相比,奥密克戎变异株感染导致胸部 CT 严重程度降低和住院结局改善。
Radiology. 2023 Jan;306(1):261-269. doi: 10.1148/radiol.220533. Epub 2022 Jun 21.
9
One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis.COVID-19 患者的 1 年随访 CT 表现:系统评价和荟萃分析。
Respirology. 2022 Aug;27(8):605-616. doi: 10.1111/resp.14311. Epub 2022 Jun 12.
10
Chest CT-based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia.基于胸部 CT 的中度 COVID-19 肺炎 1 年后结局评估。
Radiology. 2022 Nov;305(2):479-485. doi: 10.1148/radiol.220019. Epub 2022 May 10.